BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 6854151)

  • 1. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
    Van Zuiden PE; Erickson SK; Cooper AD
    J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells.
    Craig WY; Cooper AD
    J Lipid Res; 1988 Mar; 29(3):299-308. PubMed ID: 2837527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between activity of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and secretion of very-low-density-lipoprotein cholesterol by the isolated perfused liver and in the intact rat.
    Goh EH; Heimberg M
    Biochem J; 1979 Oct; 184(1):1-6. PubMed ID: 230824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of rat hepatic cholesterol metabolism. Effects of lipoprotein composition on acyl coenzyme A:cholesterol acyltransferase in vivo and in the perfused liver and on hepatic cholesterol secretion.
    Van Zuiden PE; Cooper AD; Erickson SK
    J Lipid Res; 1987 Aug; 28(8):930-40. PubMed ID: 3668389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential influence of different dietary fatty acids on very low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants.
    López-Soldado I; Avella M; Botham KM
    Metabolism; 2009 Feb; 58(2):186-95. PubMed ID: 19154951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.
    Cooper AD; Shrewsbury MA; Erickson SK
    Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethyl glutaryl coenzyme A reductase in rat liver.
    Carrella M; Fong LG; Loguercio C; Del Piano C
    Metabolism; 1999 May; 48(5):618-26. PubMed ID: 10337863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
    Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
    J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of triglyceride-rich lipoprotein secretion by fatty acids in CaCo-2 cells.
    Field FJ; Albright E; Mathur SN
    J Lipid Res; 1988 Nov; 29(11):1427-37. PubMed ID: 3241120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat.
    Kasim SE; LeBoeuf RC; Khilnani S; Tallapaka L; Dayananda D; Jen KL
    J Lipid Res; 1992 Jan; 33(1):1-7. PubMed ID: 1552226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
    Walli AK; Seidel D
    J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of free fatty acids on activity of hepatic microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase and on secretion of triglyceride and cholesterol by liver.
    Goh EH; Heimberg M
    J Biol Chem; 1977 May; 252(9):2822-6. PubMed ID: 856804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metabolism and secretion of a cholesterol-enriched lipoprotein fraction.
    Stone BG; Schreiber D; Alleman LD; Ho CY
    J Lipid Res; 1987 Feb; 28(2):162-72. PubMed ID: 3572245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and chylomicron remnant receptor activities in rat liver.
    Wade DP; Soutar AK; Gibbons GF
    Biochem J; 1984 Feb; 218(1):203-11. PubMed ID: 6324750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
    Barnard GF; Erickson SK; Cooper AD
    J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Ito T
    Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of high density lipoproteins in regulation of hepatic fatty acid synthesis by chylomicron and very low density lipoprotein remnants.
    Lakshmanan MR; Maten MV; Muesing RA; O'Looney P; Vahouny GV
    J Biol Chem; 1983 Apr; 258(8):4746-9. PubMed ID: 6833273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.